State-Specific Barriers to Methadone for Opioid Use Disorder Treatment

, , &
Journal of Law, Medicine and Ethics 51 (2):403-412 (2023)
  Copy   BIBTEX

Abstract

Opioid agonist treatment, including methadone, is the safest and most effective method for treating opioid use disorders and reduces opioid overdose deaths. While access to methadone is highly regulated by federal law, a substantial portion of states impose stricter barriers.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2023.73

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,261

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Our Ethical Obligation to Treat Opioid Use Disorder in Prisons: A Patient and Physician's Perspective.Curtis Bone, Lindsay Eysenbach, Kristen Bell & Declan T. Barry - 2018 - Journal of Law, Medicine and Ethics 46 (2):268-271.
Changing Law from Barrier to Facilitator of Opioid Overdose Prevention.Corey Davis, Damika Webb & Scott Burris - 2013 - Journal of Law, Medicine and Ethics 41 (s1):33-36.
Electronic health information system at an opioid treatment programme: roadblocks to implementation.Ben Louie, Steven Kritz, Lawrence S. Brown Jr, Melissa Chu, Charles Madray & Roberto Zavala - 2012 - Journal of Evaluation in Clinical Practice 18 (4):734-738.
An Effective Intervention: Limiting Opioid Prescribing as a Means of Reducing Opioid Analgesic Misuse, and Overdose Deaths.Brandi C. Fink, Olivier Uyttebrouck & Richard S. Larson - 2020 - Journal of Law, Medicine and Ethics 48 (2):249-258.
Opioid Treatment Agreements and Patient Accountability.Larisa Svirsky - 2021 - Hastings Center Report 51 (4):46-9.
Opioid Treatment Agreements Repurposed—But Who Monitors the Monitors?Richard Payne - 2017 - Hastings Center Report 47 (3):36-37.
The Impact of Prescription Drug Monitoring Programs on U.S. Opioid Prescriptions.Ian Ayres & Amen Jalal - 2018 - Journal of Law, Medicine and Ethics 46 (2):387-403.
Federal Regulation of Clinical Practice in Narcotic Addiction Treatment: Purpose, Status, and Alternatives.Stephen P. Molinari, James R. Cooper & Dorynne J. Czechowicz - 1994 - Journal of Law, Medicine and Ethics 22 (3):231-239.
Federal Regulation of Clinical Practice in Narcotic Addiction Treatment: Purpose, Status, and Alternatives.Stephen P. Molinari, James R. Cooper & Dorynne J. Czechowicz - 1994 - Journal of Law, Medicine and Ethics 22 (3):231-239.
The Opioid Crisis in Black Communities.Keturah James & Ayana Jordan - 2018 - Journal of Law, Medicine and Ethics 46 (2):404-421.
The Epidemic as Stigma: The Bioethics of Opioids.Daniel Z. Buchman, Pamela Leece & Aaron Orkin - 2017 - Journal of Law, Medicine and Ethics 45 (4):607-620.
Solving the Opioid Crisis Isn't Just a Public Health Challenge—It's a Bioethics Challenge.Travis N. Rieder - 2020 - Hastings Center Report 50 (4):24-32.
Opioids May be Appropriate for Chronic Pain.Paul J. Christo - 2020 - Journal of Law, Medicine and Ethics 48 (2):241-248.
Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward.Christopher T. Breen & David A. Fiellin - 2018 - Journal of Law, Medicine and Ethics 46 (2):272-278.
Civil commitment for opioid misuse: do short-term benefits outweigh long-term harms?John C. Messinger, Daniel J. Ikeda & Ameet Sarpatwari - 2022 - Journal of Medical Ethics 48 (9):608-610.

Analytics

Added to PP
2023-09-02

Downloads
12 (#1,090,149)

6 months
10 (#276,350)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references